Coltene Holding AG (CLTN.XSWX) DCF Valuation
Every assumption below is yours to change. The defaults are derived from this company's own filing history, not from a house view.
Conservative
CHF 11.47
76% overvaluedvs CHF 47.20
Base
CHF 13.42
72% overvaluedvs CHF 47.20
Optimistic
CHF 15.57
67% overvaluedvs CHF 47.20
Where today's price sits
Today's price falls outside the modelled range.
Verdict
Today's price sits above all three scenarios. Under these assumptions the stock looks overvalued, so either the growth inputs are too conservative or the price is ahead of the cash flows.
Base free cash flow
CHF 8M
Trailing twelve months
Historical FCF CAGR
-19.4%
Across 6 reported periods
Market implies
16.0%
Growth needed at 8% WACC
Terminal value share
58%
Of the base case valuation
Growth needed to justify today's price
At a 8.0% discount rate, today's price already assumes 16.0% annual free cash flow growth for ten years. Your base case assumes 2.0%, so the market is paying for growth you are not forecasting.
Curve holds terminal growth at 2.5%, years 6 to 10 at half the first-stage rate, and applies no safety margin.
Free cash flow history
The most recent period is the base every projection starts from. Compounded, that history is -19.4% a year.
Coltene Holding (CLTN.XSWX) DCF: intrinsic value and margin of safety
Intrinsiqq's two-stage DCF values Coltene Holding (CLTN.XSWX) at about CHF 17.90 per share, or CHF 13.42 with a 25% margin of safety. At CHF 47.20 the stock looks overvalued. Every assumption is adjustable below; this is analysis, not investment advice.
Frequently asked
What is Coltene Holding's (CLTN.XSWX) fair value?+
Intrinsiqq's two-stage discounted cash flow (DCF) model estimates an intrinsic value of about CHF 17.90 per share for CLTN.XSWX. It projects recent free cash flow forward at a growth rate that fades toward a long-run rate, then discounts those cash flows back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around CHF 13.42. The output moves with the growth and discount-rate inputs, so it is best read as a range, not a single number. You can change every assumption with the sliders on this tab.
Is Coltene Holding overvalued based on a DCF?+
At CHF 47.20, CLTN.XSWX trades above the base-case intrinsic value of about CHF 17.90, a 62.1% premium over that estimate, so on this model it looks overvalued. A DCF is only one lens: a premium can be justified if the business grows faster or is higher quality than the base case assumes, which is exactly what the sliders let you test.
What growth is priced into Coltene Holding?+
The base case grows CLTN.XSWX's free cash flow at about 2.0% a year before fading, against roughly -19.4% historical free-cash-flow growth. If the price implies growth well above what the company has actually delivered, the market is paying for optimism; if below, expectations are modest. Adjust the growth assumption on this tab to see what the current price is really betting on.
What is a good margin of safety for Coltene Holding?+
A margin of safety is the discount to intrinsic value you demand before buying, to protect against being wrong on the inputs. Intrinsiqq applies 25% by default, which turns CLTN.XSWX's CHF 17.90 intrinsic estimate into a CHF 13.42 entry. Wider margins suit less predictable businesses; you can set your own on this tab. This is analysis from company filings, not investment advice.
Related stocks: Medical Instruments & Supplies
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.